levonorgestrel has been researched along with Bacterial Vaginitides in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Agbemenu, K; Auerbach, S; Daniel, AL; Lorenz, R; Nazarenko, D | 1 |
| Baeten, JM; Balkus, JE; Brown, ER; Bunge, KE; Chappell, C; Hillier, SL; Jeenarain, N; Kiweewa, FM; Makanani, B; Naidoo, L; Palanee-Phillips, T; Peebles, K; Reynolds, D; Singh, D | 1 |
| Dawood, R; Masood, A; Rezk, M; Sayyed, T | 2 |
| Bellen, G; Donders, GGG; Ruban, K; Van Bulck, B | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Bunge, K; Chappell, CA; Hillier, SL; Meyn, LA; Moncla, BJ; Rohan, LC; Wang, L | 1 |
| Blithe, DL; Brooks, JP; Buck, GA; Edwards, DJ; Fettweis, JM; Jefferson, KK; Serrano, MG; Sheth, NU; Strauss, JF | 1 |
| Keane, F; Knight, I; Neale, R | 1 |
| Bellen, G; Berger, J; Cornelis, A; Donders, GG; Heuninckx, H | 1 |
| Roy, S | 1 |
2 review(s) available for levonorgestrel and Bacterial Vaginitides
| Article | Year |
|---|---|
An Integrative Review of the Relationship Between Intrauterine Devices and Bacterial Vaginosis.
Topics: Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Retrospective Studies; Vaginosis, Bacterial | 2023 |
Nonbarrier contraceptives and vaginitis and vaginosis.
Topics: Candidiasis, Vulvovaginal; Contraceptive Devices, Female; Contraceptives, Oral; Female; Humans; Incidence; Intrauterine Devices; Levonorgestrel; Logistic Models; Odds Ratio; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial | 1991 |
1 trial(s) available for levonorgestrel and Bacterial Vaginitides
| Article | Year |
|---|---|
Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
Topics: Administration, Intravaginal; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Prevalence; Vagina; Vaginosis, Bacterial | 2009 |
8 other study(ies) available for levonorgestrel and Bacterial Vaginitides
| Article | Year |
|---|---|
Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study.
Topics: Adolescent; Adult; Cohort Studies; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Longitudinal Studies; Middle Aged; Prospective Studies; Vaginosis, Bacterial; Young Adult | 2021 |
Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS.
Topics: Adult; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Trichomonas vaginalis; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial; Young Adult | 2017 |
Reply to letter to editor regarding: Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception compared to levonorgestrel-releasing intrauterine system.
Topics: Candida albicans; Contraception; Female; Humans; Levonorgestrel; Trichomonas vaginalis; Vaginosis, Bacterial | 2018 |
Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.
Topics: Adult; Candida; Female; Humans; Intrauterine Devices, Medicated; Lactobacillaceae; Levonorgestrel; Microbiota; Prospective Studies; Time Factors; Vagina; Vaginosis, Bacterial | 2018 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
The effects of reproductive hormones on the physical properties of cervicovaginal fluid.
Topics: Adolescent; Adult; Body Fluids; Cervix Uteri; Contraception; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Proteins; Vagina; Vaginal Smears; Vaginosis, Bacterial; Viscosity | 2014 |
Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
Topics: Adolescent; Adult; Condoms; Contraception; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Microbiota; Polymerase Chain Reaction; Retrospective Studies; RNA, Ribosomal, 16S; Sexually Transmitted Diseases, Bacterial; Vagina; Vaginosis, Bacterial; Young Adult | 2017 |
Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device.
Topics: Candida; Candidiasis; Chi-Square Distribution; Cohort Studies; Contraception; Contraceptive Agents, Female; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mobiluncus; Papanicolaou Test; Pilot Projects; Retrospective Studies; Vagina; Vaginal Smears; Vaginitis; Vaginosis, Bacterial | 2011 |